Clinical Trials on Congenital Muscular Dystrophy Type 1A in Canada
Total 592 results
-
Canadian Myeloma Research GroupCompleted
-
GlaxoSmithKlineCompletedMultiple MyelomaUnited States, Canada, United Kingdom
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Fundacion Para La Investigacion Hospital La FeUnknown
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
PfizerCompletedPolycystic Kidney, Autosomal DominantUnited States, Canada, Australia, Sweden, Spain, Poland, Korea, Republic of, Switzerland, United Kingdom, Moldova, Republic of, Italy, Czech Republic, Hungary, Lithuania, Romania, Slovakia, Turkey
-
University Health Network, TorontoRecruitingMelanoma | Lymphoma | Kidney Cancer | Leukemia | Cancer | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lynch Syndrome | Lung Cancer | Colon Cancer | Meningioma | BRCA1 Mutation | BRCA2 Mutation | Myeloma | Mutation | Uterine Cancer | Cowden SyndromeCanada
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BUnited States, Canada, United Kingdom, France, Malaysia, Brazil, Croatia, Germany, Italy, Japan, Taiwan
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
CARsgen Therapeutics Co., Ltd.Active, not recruitingMultiple MyelomaUnited States, Canada
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedCardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | HypercholesterolemiaUnited States, Canada
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Jaeb Center for Health ResearchFoundation Fighting BlindnessActive, not recruitingUsher Syndrome, Type 2A | Retinitis Pigmentosa 39United States, Canada, France, Germany, Netherlands, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaSpain, Canada, United States
-
Thunder Bay Regional Health Research InstituteLakehead University; St. Joseph's Care Group; Thunder Bay Regional Health Sciences...RecruitingBronchiectasis | Chronic Obstructive Pulmonary Disease | Asthma | Obstructive Sleep Apnea | Emphysema | Pulmonary Fibrosis | Lung Cancer | Cystic Fibrosis | Mesothelioma | Pulmonary Hypertension | Interstitial Lung Disease | Pulmonary Embolism | Lung Resection | Lung Transplant | Seasonal Allergies | Lung Infection | Asbes... and other conditionsCanada
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Ontario Clinical Oncology Group (OCOG)Ontario Cancer Research NetworkCompletedVenous Thromboembolism | Brain TumorsUnited States, Canada
-
Solvay PharmaceuticalsCompletedHypertension | Type 2 DiabetesFrance, Canada, Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaCanada, Germany
-
Genentech, Inc.CompletedMultiple MyelomaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultiple MyelomaUnited States, Canada
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States, Austria, Spain, Japan, Croatia, Italy, United Kingdom, Israel, Sweden, Ukraine, Malaysia, Greece, Denmark, Canada
-
British Columbia Cancer AgencyRecruitingPituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary CarcinomaCanada
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPolycystic Kidney, Autosomal DominantBelgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy
-
PETHEMA FoundationJanssen, LP; Adknoma Health ResearchRecruitingMultiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)Spain
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain